Stop Guessing What to Tell Your CCCA Patients: The Research Has Already Answered It
If you have been following this series, you already know that CCCA is no longer a condition without a treatment rationale. You know the molecular targets, the mechanism-based therapies, and why early intervention changes outcomes. What the previous articles could not give you is the language, the specific clinical framing that makes the science land in the exam room with a patient who has spent years being told this was her fault. That is what this article is for. This is part four of the CCCA series. You can read it in about eight minutes or listen to the audio version above. Either way, what follows are eight clinical pearls drawn directly from the current evidence.
This is a multiple-part series. Join the email list to be notified when each article is published:
+ Why We Are Investigating the Link Between Fibroids, Keloids, and Hair Loss (And Why We Need an Illustrator to Do It). Read here.
+ Entrepreneurial Opportunities and Business Strategies
CLINICAL PEARLS: KEY TEACHING POINTS FOR PATIENT EDUCATION
She Has Spent Years Thinking It Was Her Fault. Start There.
Effective patient education in CCCA requires clear, evidence-based explanations that address common misconceptions and set realistic expectations. Research on treatment adherence and patient outcomes suggests certain teaching points are particularly important:
Many patients have spent years being told their hair loss is entirely their fault, that they "damaged" their hair with braids, relaxers, or heat. While those factors can trigger or worsen CCCA, the underlying vulnerability is genetic. The 2019 New England Journal of Medicine study found that 24% of CCCA patients carry mutations in PADI3, a gene essential for building strong hair shafts. This helps patients understand the condition isn't about blame but biology. A useful teaching metaphor: The PADI3 mutation does not cause hair loss on its own. It creates a biological susceptibility that mechanical stress, chemical trauma, and inflammation can trigger. Treatment works by addressing that underlying vulnerability, not just managing what is visible on the surface.
"I want to address something before we go any further, because I hear this from a lot of my patients. This is not something you did to yourself. There is a gene that some people carry that makes their hair shafts more fragile than average. That gene was there before the braids, before the relaxer, before anything else. Those things may have accelerated what was already happening underneath, but they did not cause it. You did not cause this. What we are doing now is treating the biology, not the behavior."
The Scalp Looks Calm. The Fibrosis Is Not.
Inflammation is only part of the story, fibrosis drives permanent loss. Patients often ask why their scalp doesn't look particularly inflamed if this is an inflammatory condition. The fibroproliferative model explains this discordance: fibrosis (scar tissue forming around hair follicles) progresses at a rate disproportionate to visible inflammation. The inflammation may have started the process, but the scar tissue makes it permanent. This explains why newer treatments don't just reduce inflammation but also reverse fibrosis, like metformin activating AMPK enzymes that signal the body to stop laying down excessive scar tissue and begin breaking down existing fibrosis.
"Something I want you to understand about what is happening on your scalp is that the part you can see, any redness or tenderness, is only one piece of it. Underneath the surface, your body has been forming scar tissue around your hair follicles. That scar tissue is what makes the loss permanent, because once it fully replaces a follicle, that follicle cannot grow hair anymore. The reason this matters is that your scalp may look calm and still be progressing. That is why we treat even when things look quiet. We are not just treating what you can feel. We are treating what is happening underneath."
When She Mentions Her Fibroids, That Is Your Opening
Hair follicles and uterine fibroids share molecular pathways. Research demonstrates that women with CCCA have a five-fold increased occurrence of uterine fibroids compared to matched controls. These conditions share fibroproliferative pathways involving dysregulated collagen production and abnormal extracellular matrix remodeling. Patients with both conditions often recognize this connection: "My mother had both too." Understanding that certain individuals have a tendency toward excessive scar tissue formation in different body systems - scalp, uterus, dermis(keloids) - helps patients understand they're not dealing with separate random problems but with a coherent biological pattern. This also means targeting the underlying fibroproliferative pathway could potentially help multiple conditions.
"I want to ask you something. Have you ever been told you have uterine fibroids? The reason I ask is that research shows women with this type of hair loss are significantly more likely to also have fibroids. That is not a coincidence. Both conditions involve the same underlying process, your body forming excessive scar tissue in different locations. Your scalp, your uterus, and in some cases your skin are all affected by the same biological tendency. Understanding that helps us look at the full picture of your health, not just your hair."
The Hair She Is Losing Today Started Breaking Beneath the Surface Weeks Ago
Internal follicular damage precedes visible hair loss. Many patients focus on the hair they're losing and assume if shedding decreases, they're improving. But in CCCA, the hair shaft breaks inside the follicle, beneath the scalp surface. This means increased shedding when treatment starts working can actually represent progress, damaged hair shafts stuck in dying follicles are finally being expelled so new, healthier hair can grow. This teaching point is crucial for managing expectations during the first few months of treatment when shedding might increase before improvement occurs.
"I want to prepare you for something that can feel alarming but is actually a sign that treatment is working. In the first weeks or months, you may notice more shedding than usual. Here is what is happening: the hair shafts that were already damaged and stuck inside your follicles are finally being released. That is your scalp clearing out what was not healthy so that something new can grow. It can feel like things are getting worse before they get better. They are not. If the shedding increases early on, that is often progress. Call me if you are concerned, but do not stop the treatment."
The Patient Who Quits at Month Two Was Never Told What Month Two Would Feel Like
Hair regrowth requires months, not weeks. Hair grows slowly. The hair visible today started growing four to six months ago. If treatment starts today and works perfectly, visible results won't appear for at least three to four months, with maximal benefit at six to twelve months. The teaching metaphor: "We're not looking for a quick fix. We're healing scalp tissue from the inside out and then growing healthy hair on healed skin. That takes time, patience, and consistency." Setting this expectation upfront prevents patients from abandoning effective treatment prematurely because they expected faster results.
"I need to set an expectation with you today so that you do not get discouraged and stop something that is working. The hair you see on your head right now started growing four to six months ago. That is how slow the hair growth cycle is. If this treatment works perfectly starting today, you will not see visible results for at least three to four months, and the full benefit may take six months to a year. We are not looking for a fast result. We are healing tissue from the inside and then growing healthy hair on top of healed skin. That takes time. I will be tracking your progress at every visit so we have an objective record, even when it is hard to see the changes day to day."
This Is Not a Course of Antibiotics. Make Sure She Knows That at the First Visit
Disease control requires long-term management. CCCA isn't like an infection treated with antibiotics until cured. It's a chronic condition requiring ongoing management. The comparison to managing diabetes or hypertension helps: treatment works as long as it's maintained, but discontinuing treatment often means the condition returns. Some patients can reduce treatment intensity once they achieve stability, but most need at least some maintenance therapy indefinitely. This conversation should happen at diagnosis, not six months into treatment when patients expect to discontinue therapy.
"I want to have an honest conversation with you about what managing this condition looks like long term, because I would rather tell you now than six months from now when you are expecting to be done. This is not like an infection where you finish a course of medication and it is gone. This is a chronic condition, similar to managing blood pressure or diabetes. The treatment works as long as we maintain it. If we stop, the condition often comes back, sometimes quickly. What I can tell you is that once we get things stable, we may be able to reduce the intensity of treatment. But most patients need some level of ongoing care indefinitely. Our goal is to find the least amount of treatment that keeps things under control."
She Can Still Wear Her Braids. That Is Part of the Clinical Conversation.
Hair care modifications support treatment but aren't the whole solution. Effective counseling helps patients identify practices adding excessive mechanical stress, braids pulled very tight to last longer, relaxers overlapping onto previously treated hair, daily flat ironing at high temperatures, and problem-solve modifications together. But communication should make clear that reasonable modifications to reduce trauma are important, not elimination of all cultural hair practices. Patients can still wear braids if they choose, but they should be done more gently (two-strand twists tend to be more gentle, taken down more frequently, and rotated with lower-tension styles to give follicles breaks from constant pulling.
"Is it okay if we talk about your hair routine? I want to be clear that this is not a conversation about telling you to stop doing what you love or what works for your life. This is about identifying the specific things that may be adding stress to follicles that are already vulnerable. Braids worn very tight for weeks at a time, relaxers applied on top of previously treated hair, flat ironing at high heat every day, those are the things we want to look at together. You can still wear braids. You can still have a routine that works for you professionally and personally. We are just looking for modifications that give your follicles a break without taking away your choices."
When You Explain How the Medication Works, She Stays on It
Mechanism-based treatments target disease pathways, not just symptoms. When prescribing topical metformin or JAK inhibitors, explaining the mechanism helps patients understand these aren't generic anti-inflammatories. Metformin activates an enzyme (AMPK) that's underactive in CCCA scalps, signaling the body to stop making excessive scar tissue and start breaking down existing fibrosis. JAK inhibitors block the chemical signals (JAK-STAT pathway) that tell immune cells to attack hair follicles. These are targeted interventions addressing the specific molecular pathways driving disease. Patients who understand this precision often engage more seriously with treatment.
Without the medical or scientific jargon:
"I want to take a minute to explain what this medication is actually doing, because it is not just reducing inflammation the way a steroid would. Your body has a process that has been laying down scar tissue around your hair follicles. This medication works by switching that process off and signaling your body to start breaking down the scar tissue that is already there. It is doing a very specific job at the source of the problem, not just calming things down on the surface. That is why it works differently than what you may have tried before, and why staying consistent with it matters so much. The medication cannot do its job if it is not being used regularly."
"Your immune system has been sending signals that are telling your body to attack your own hair follicles. This JAK inhibitor medication blocks those specific signals. It is not suppressing your entire immune system. It is interrupting the exact communication pathway that is driving the damage. Think of it as stopping a very specific message from being delivered, so your follicles stop being treated like a problem that needs to be eliminated."
About the Author
Dr. Kimberly Madison, DNP, AGPCNP-BC, WCC, is a Board-Certified, Doctorally-prepared Nurse Practitioner, educator, and author dedicated to advancing dermatology nursing education and research with an emphasis on skin of color. As the founder of Mahogany Dermatology Nursing | Education | Research™ and the Alliance of Cosmetic Nurse Practitioners™, she expands access to dermatology research, business acumen, and innovation while also leading professional groups and mentoring clinicians. Through her engaging and informative social media content and peer-reviewed research, Dr. Madison empowers nurses and healthcare professionals to excel in dermatology and improve patient care.
.svg)
.svg)
.svg)
